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ABSTRACT
Controlled release floating metformin hydrochloride microbeads were prepared and optimized using a blend
of varying concentrations of freeze-dried pregelatinized Chinese yam starch (Dioscorea oppositifolia L) and
sodium alginate. Floating microbeads were prepared by the ionotropic gelation method using 10% w/v
calcium chloride as the cross-linking agent and sodium bicarbonate as the gas releasing agent. A full 32
factorial design was used to investigate the influence of two variables: concentrations of starch (X1) and
sodium bicarbonate (X2) on the swelling, floating lag time and amount of drug released after 1 hour (Q1) and
10 hours (Q10). Potential variables such as the concentrations of drug and total polymer were kept constant.
The results showed that the properties of the floating microbeads were significantly (p<0.01) affected by the
concentration of the modified Chinese yam starch. Buoyancy and drug release appeared to be facilitated by
increased concentrations of both starch and sodium bicarbonate in the formulation. The results also show
that an optimized formulation of metformin hydrochloride could be obtained with the potential for
gastroretentive controlled drug delivery using a blend of  freeze-dried pregelatinized  Chinese yam starch and
sodium alginate. 
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INTRODUCTION
During the last two decades tremendous
advances have been made in the development
of oral controlled drug delivery systems (1-3).
Some of the advantages include improved
therapeutic efficacy, ease of administration of
dosing, flexibility when formulating a drug, and
patient compliance (3). However, a major
constraint of these delivery systems is that not
all drug candidates are absorbed uniformly
throughout the gastrointestinal tract. One of
the approaches for achieving prolonged and
predictable drug delivery profiles in the
gastrointestinal tract is to control the gastric
residence time using Gastroretentive Dosage
Forms (GRDFs). With GRDFs, the dosage
form is retained in the stomach for a prolonged
period of time while the drug is released
continuously, thus ensuring optimal bioavaila-
bility. One of the approaches to increase the
retention of an oral dosage form in the stomach
is to use a Floating Drug Delivery System
(FDDS) (4). An FDDS has a lower bulk density
than the gastric fluid, and without affecting the
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gastric emptying rate, remains buoyant in the
stomach for a prolonged period of time (5).
The drug is released slowly from the delivery
system while the dosage form is floating on the
gastric contents leading to reduced fluctuations
in plasma drug concentrations (6). The FDDSs
utilize matrices prepared with swellable
polymers such as polysaccharides, e.g., sodium
alginate, and an effervescent component, e.g.,
sodium bicarbonate, citric or tartaric acids or
matrices containing chambers of liquid that
gasify at body temperature. On arrival in the
stomach, the carbon dioxide is liberated from
the matrices by the acidity of the gastric
contents and then entrapped in the gelatinous
hydrocolloid which causes an upward motion
of the dosage form to float on top of the
chyme. The carbonates, in addition to
imparting buoyancy to these formulations, also
provide the initial alkaline microenvironment
for the polymer to gel (6).
Drug formulation studies often involve a great
number of experiments and much time and
effort is usually expended, especially when
developing complex formulations. The number
of experiments can be reduced by the use of an
experimental design which can be an efficient
method for indicating the relative significance
of a number of formulation variables and their
interactions with each other (7). It also allows
the formulation studies to be completed within
the shortest possible time, resulting in cost
savings and the reduction of raw materials used.
Moreover, the effects of the independent
variables and their interactions can be
evaluated. One such experimental design is the
32 factorial statistical model which incorporates
interactive and polynomial terms to evaluate the
responses of the various formulation and
process variables (7).
Starch is a well-known excipient but lately there
has been a growing interest in starch
microspheres for delivery of active substances
via several different routes of administration.
This is because starch is known to have low
toxicity, is biodegradable and yet quite stable in
a biological environment (8-10). Most studies
have used a blend of proprietary starches such
as corn, potato and rice starches  (8, 9) and
polymers,  such as sodium alginate, to modulate
drug release from mucoadhesive microbeads.
Controlled release was achieved only when the
microbeads were coated with HPMC (9). It has
been shown that starches from different
sources vary in their physicochemical and
functional properties. Starches containing
mainly amylopectin and traces of amylose have
been shown to have great potential as novel
mucoadhesive polymers. This is due to the free
hydroxyl groups that open up the possibility for
the starch to be crosslinked with other
polymers for controlled drug release (11).
A new starch that could be explored
commercially in the food and pharmaceutical
industries is the starch from the Chinese yam
found in the tubers of Dioscorea oppositifolia L,
Family Dioscoreaceae, a staple root crop found
in China and parts of Africa (12). The tubers
have a starch content of 64% w/w (dry weight
basis) and the starch has shown promising
potential as a disintegrant or binder in tablet
formulations (13). Native Chinese starch which
consists of 78.4% amylopectin (12) has been
modified by pregelatinization followed by
freeze drying and characterized as a
pharmaceutical excipient (14). The modified
Chinese yam starch has been used in
combination with sodium alginate for the
formulation of floating gastroretentive
microbeads for the controlled delivery of
metformin hydrochloride (hereafter referred to
as MET) (10). The  spherical, discrete and free
flowing floating microbeads were prepared
using a blend of the modified Chinese yam
starch and sodium alginate at different
concentrations using sodium bicarbonate as a
gas-generating agent. The beads provided
controlled release of MET, buoyancy was
maintained for up to 12 hours. The
formulations released the drug by diffusion and
erosion controlled mechanisms of drug release
which appeared to be controlled by varying the
starch to alginate polymer ratio. However, the
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effects of important formulation variables on
these novel microbeads have not been fully
evaluated. Thus in the present study, a full 32
factorial experimental design has been used to
evaluate the influence of two variables:
concentrations of starch (X1) and sodium
bicarbonate (X2) on the floating lag time,
swelling and drug release properties of MET
microbeads.
The metformin hydrochloride, used as the
model drug, is an orally administered biguanide
derivative widely used in the treatment of non-
insulin dependent diabetes mellitus. It has a
half-life of approximately 4-6 hours (15). The
immediate re lease formulations are
administered 2-3 times daily and are associated
with a high incidence of side effects (16).
Various controlled release formulations of
MET have been developed in order to optimize
therapy and patient compliance. However,
burst release which is undesirable has been
reported for the controlled release tablets (15).
Floating controlled release microbeads could
offer a better means of delivering the drug in a
controlled manner, thus avoiding low and
erratic bioavailability and optimizing therapy.
MATERIALS AND METHODS
Materials
The materials used were Metformin
hydrochloride USP (C4H11N5.HCl, MW =
165.62) which was kindly provided by Zydus
Cadila   Healthcare  Ltd.  (Ahmedabad,   India) 
(shown in Figure 1) sodium  alginate
(C6H9O7Na, MW = 40,000) which was obtained
from S.D. Fine Chemicals (Mumbai, India) and
calcium carbonate and sodium bicarbonate
which were obtained from Finar Chemicals Ltd.
(Ahmedabad, India). Tubers of Dioscorea
oppositifolia L (Chinese yam) were obtained from
local farmers in Ibadan, Nigeria and
authenticated. The description of the extraction
and modification procedures and the properties
of the starch have been reported elsewhere (12,
13). All other reagents used were of analytical
grade.
Preparation of floating microbeads
The microbeads were prepared by the
ionotropic gelation method using a gel blend of
freeze dried pregelatinized Chinese yam starch
and sodium alginate (17, 18). The concentration
of the drug (2% w/v) and total polymer
(2% w/v) was kept constant. The required
amount of drug was dispersed in 100 ml
solution of modified Chinese yam starch (1.0,
1.3 and 1.60% w/v) by stirring with a magnetic
stirrer for 60 minutes. Varying quantities of
sodium bicarbonate (1.0, 1.5, 2.0% w/v
solution) were added to the sodium alginate
solution. The two gels were blended and
homogenized to obtain a suitable starch-sodium
alginate blend. The resulting dispersion was
extruded into calcium chloride solution (10%
w/v), maintained under gentle agitation (400
rpm) using a syringe with 0.90 mm needle at a
dropping rate of 2 ml/minute. The velocity and
height of extrusion were kept constant to
ensure uniformity of bead size. After curing for
15 minutes, the beads were collected by
decantation, washed in ethanol and, then dried
for 10 hours at room temperature followed by 6
hours in a hot-air oven at 40°C. The content of
MET in the microbeads was determined using a
UV spectrophotometer (UV-1700 Schimadzu,
Japan) at 233 nm. The calibration curve was
linear based on Equation (1): 








Figure 1 Metformin Hydrochloride USP
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Size and morphology
The particle size of the microbeads were
determined using optical microscopy while the
morphology and surface characteristics of the
microbeads were analyzed using scanning
electron microscopy (XL 30 ESEM, Philips,
Eindhoven, Netherlands) at an accelerating
voltage of 30 KV.
Floating ability and Swelling Index
The floating ability of the microbeads was
determined by placing the beads in a dissolution
apparatus containing 0.1N HCl (900 ml). The
time taken for the beads to rise to the surface
and float was taken as the floating lag time
(FLT) (19).
The swelling index was determined by soaking
0.5 ml of the microbeads in 5 ml of 0.1 N HCl
in a 10 ml measuring cylinder. The volume of
the microsphere beads was determined after 12
hours. Swelling index was calculated using
Equation 2 (20).
Eq. 2Swelling Index  
Volume after 12  hours (ml)
Original  volume (ml)
=
Drug release study
The in vitro dissolution studies were carried out
using the USP XXI paddle method at 50 rpm in
900 ml of 0.1 N Hydrochloric acid (pH 1.2)
maintained at 37 ± 0.5°C. The quantity of
microbeads containing 200 mg of MET was
used and samples (10 ml) were withdrawn at
different intervals and replaced with equal
amounts of fresh medium. The sample was
diluted and the amount of MET released was
determined at a wavelength of 233 nm, using a
UV/VIS spectrophotometer (Schimadzu 1700,
Japan). Determinations were carried out in
triplicate.
Factorial experimental design
A full 32 factorial experimental design was
performed using two factors, each at three
levels (21). The nine possible combinations are
shown in Table 1. The concentration of starch
(X1) and sodium bicarbonate (X2) were chosen
as independent variables while the swelling
index (S), floating lag time (FLT) and quantities
of drug released in 1 hour (Q1) and 10 hours
(Q10) were selected as dependent variables. The
data were subjected to multiple regression
analysis using statistical software (Systat®,
Systat Software Inc., Chicago, IL.). The model
incorporating first order polynomial terms was
used to evaluate the responses and the
Equation (3) used was:
Y = b0 + b1X1 + b2X2 +b12 X1X2 + b11X12 + b22X22 Eq. 3
where, Y is the dependent variable, b0 is the
arithmetic mean response of the 9 runs and b1 is
the estimated coefficients for the related factor
X1. 
The main effects (X1 and X2) represent the
average result of changing one factor at a time
from its low to high value. The interaction term
“X1X2”shows how the response changes when
the two factors change simultaneously. The
polynomial terms (X12 and X22) are included to
investigate non-linearity. Each experiment was
conducted in triplicate and the mean
determined.
Data analysis
To compare the differences between the
formulations, statistical analysis was carried out
using the analysis of variance (ANOVA) using
GraphPad Prism© 4 (Graphpad Software Inc.
San Diego, CA). At the 95% confidence




The composition of the modified Chinese yam
starch-alginate blends used for the formulation
of the floating microbeads is presented in
Table 1.
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Table 1 Composition of polymers for the floating microbeads
CONTENT B1 B2 B3 B4 B5 B6 B7 B8 B9
Sodium Alginate (% w/v) 1.00 1.00 1.00 0.70 0.70 0.70 0.40 0.40 0.40
Starch (% w/v) 1.00 1.00 1.00 1.30 1.30 1.30 1.60 1.60 1.60
Table 2 The 32 Factorial Design for the formulation (the independent variables are starch concentration (X1) and





REAL VALUES DEPENDENT VARIABLES









B1 -1 -1 1.00 1.00 40.00 1.55 1.82 40.82
B2 -1 0 1.00 1.50 30.50 1.60 1.94 42.68
B3 -1 +1 1.00 2.00 21.00 1.62 2.96 51.84
B4 0 -1 1.30 1.00 22.10 2.12 5.15 63.78
B5 0 0 1.30 1.50 20.22 2.32 7.12 65.37
B6 0 +1 1.30 2.00 15.50 2.35 8.14 70.11
B7 +1 -1 1.60 1.00 10.00 2.60 9.15 71.78
B8 +1 0 1.60 1.50 8.35 2.65 9.32 74.37
B9 +1 +1 1.60 2.00 6.50 2.68 10.09 75.99
The properties of the prepared microbeads
used for the factorial design are shown in
Table 2, while the results of the multiple
regression  analysis  are  summarized in Table 3.
Table 3 Summary of regression outputs of significant





FLH Swelling Q1 Q10
bo 19.33 2.13 5.97 61.86
b1 -11.11 0.53 3.64 14.47
b2 -4.85 0.06 0.85 3.59
b12 -1.38 0.04 0.30 1.79
b11 0.12 0.15 -0.92 -6.84
b22 -0.51 -0.04 0.09 1.58
R2 0.928 0.968 0.962 0.920
The results were found to fit the polynomial
regression equation with a correlation
coefficient, r $ 0.920 for all the dependent
variables. The drug entrapment efficiency of
the microbeads increased with an increase in
the concentration of the polymer and ranged
from 30.55±4.40 to 55.20±5.45%. Floating
microbeads are expected to remain buoyant in
the stomach without affecting the gastric
emptying rate for a prolonged period of time.
The time taken for the beads to rise from the
bottom of the flask to the surface and float is
regarded as floating lag time (FLT). The factors
X1 and X2 showed negative effects on the FLT
indicating that the time taken for the
formulation to float to the surface of the
medium decreased with increase in the
concentration of starch and sodium
bicarbonate. When the beads come in contact
with an acidic medium, sodium bicarbonate
effervesces, releasing carbon dioxide which
imparts buoyancy to the microbeads while
providing an alkaline environment for gelation
and crosslinking of the polymer to provide a gel
barrier at the surface of the formulation (22).
The released carbon dioxide lowers the density
of the beads making them more buoyant for a
prolonged period of time. The effect of starch
concentration on the floating properties of the
microbeads was significantly (p<0.01) higher
than  those of  sodium  bicarbonate.  This  indi-
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X1 2 1.707 0.854 329.03 0.000
X2 2 0.027 0.013 5.16 0.078
Residual 4 0.010 0.003
Total 8 1.744
Floating lag time
X1 2 740.398 370.199 21.74 0.007
X2 2 141.648 70.824 4.16 0.105
Residual 4 68.108 17.027
Total 8 950.154
Q1
X1 2 81.203 40.601 101.12 0.000
X2 2 4.301 2.150 5.36 0.074
Residual 4 1.606 0.402
Total 8 87.110
Q10
X1 2 1349.28 674.639 151.23 0.000
X2 2 82.47 41.233 9.24 0.032
Residual 4 17.84 4.461
Total 8 1449.59
cates  that  the  modified  starch   conferred  a
higher degree of buoyancy to the microbeads
than sodium bicarbonate which could probably
be due to the nature of the starch (14). The
results of the two-way ANOVA presented in
Table 4, indicates that the concentration of
starch significantly (p<0.01) affected the FLT
while the effects of sodium bicarbonate was not
statistically significant (p>0.05) over the range
of the investigation. The interactive terms X1
and X2 also showed negative values indicating
that both variables interact to decrease the
floating lag time of the microbeads.
SEMs of the microbeads containing different
concentrations of the modified starch are
presented in Figure 2. They show that the
microbeads were spherical in shape and their
surfaces appeared to be coated by the starch,
thus making the beads more porous. The
porosity appeared to increase as the amount of
starch increased producing more buoyant beads
and thus reducing the FLT. The average
particle size of the beads also increased (from
1.10 mm to 1.50 mm) with the increase in the
concentration of starch.
Both factors X1 and X2 showed positive effects
on the swelling index indicating that increasing
the concentrations of starch and sodium
bicarbonate led to an increase in the swelling
properties of the beads. This could be due to
the high water sorption capacity of the starch
and the surface characteristics of the
microbeads. The results of the two-way
ANOVA also indicate that the swelling
property of the microbeads was significantly
(p< 0.001) dependent on the concentration of
starch present is the formulation. The positive
value of X12 indicates positive linearity in the
effectiveness of starch to aid swelling as the
concentration increased. The interactive terms
Figure 2 SEM images showing shapes and the surface
characteristics of floating microbeads (i) B3, (ii) B6 and
(iii) B9.
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X1 and X2 showed positive effects on swelling,
thus indicating that swelling increased when
both variables were simultaneously increased.
The drug dissolution profiles of the microbead
formulations are shown in Figure 3, while the
percentage of drug released after 1 hour (Q1)
and 10 hours (Q10) are also shown in Table 2.
The drug release profiles show that the beads
did not exhibit burst release. This suggests that
the drug was not loosely bound to the surface
of the microbeads but embedded into the bead
structure (8). The drug was released at a
controlled rate from the beads probably as a
result of the combined effects of the cross-
linked polymer network of sodium alginate and
the swollen starch. The percentage of drug
released after 1 hour (Q1) and 10 hours (Q10)
shown in Table 2 appeared to be dependent on
the concentration of starch in the microbeads
(23). The values of the coefficients calculated
from the multiple regression analysis clearly
indicate that the responses were strongly
dependent on the two factors studied. The
effect of the concentration of starch on the
amount of drug release after 1 hour and 10
hours was significantly (p<0.05) higher than the
effects of the concentration of sodium
bicarbonate. The results from the two-way
ANOVA indicate that the concentration of
starch significantly (p<0.001) increased the
amount of drug release while the effects of the
concentration of sodium bicarbonate was only
significant (p<0.05) on the amount released
after 10 hours. This is in agreement with
previous studies (23, 24) and may be attributed
to the fact that the presence of starch renders
the gel matrix more porous as shown in Figure
2, thereby facilitating drug release. The
interactive terms X1 and X2 showed positive
values for the amount of drug release,
indicating that the two variables interact
synergistically to increase the amount of drug
released from the floating microbeads.
Surface plots which can assist in understanding
the influence of the variables on the properties
of the floating microbeads were generated for
all dependent variables as shown in Figure 4.
Surface plots have been used to describe the
influence of the variables on the properties of
the floating microbead (7, 8). Generally, the
steeper the slope, the stronger the interaction
between the variables. The surface plots
showed that while the starch and sodium
bicarbonate interact strongly to decrease the
floating time, they also increase the swelling
properties of the microbeads. On the other
hand, the two variables interact strongly to
increase the amount of drug released after 1
hour and 10 hours. This indicates that the
concentration of the modified starch could be
used to modulate the drug release properties of
the floating microbeads.
CONCLUSION
This study investigated the preparation of
optimized floating metformin hydrochloride
microbeads using freeze-dried pregelatinized
Chinese yam starch and sodium alginate
polymer blends. The results of the 32 factorial
design revealed that the concentrations of the
modified Chinese yam starch significantly
(p<0.01) affected the swelling, floating lag time
and drug release properties of the beads. The
concentration  of  the  modified  starch  can  be 
Figure 3 In vitro dissolution profiles of the floating
microbeads.
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altered to control the floating lag time and the
drug release properties of the microbeads
depending on the desired drug release rate.
Thus, an optimized formulation of metformin
hydrochloride microbeads could be developed
for controlled drug delivery.
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